Free Trial
NASDAQ:LEGN

Legend Biotech (LEGN) Stock Price, News & Analysis

Legend Biotech logo
$31.48 +0.05 (+0.14%)
As of 10:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Legend Biotech Stock (NASDAQ:LEGN)

Advanced

Key Stats

Today's Range
$31.24
$31.87
50-Day Range
$31.44
$40.77
52-Week Range
$27.34
$51.77
Volume
122,170 shs
Average Volume
1.41 million shs
Market Capitalization
$5.81 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$71.33
Consensus Rating
Moderate Buy

Company Overview

Legend Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

LEGN MarketRank™: 

Legend Biotech scored higher than 57% of companies evaluated by MarketBeat, and ranked 474th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Legend Biotech has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 10 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Legend Biotech has a consensus price target of $74.22, representing about 136.1% upside from its current price of $31.44.

  • Amount of Analyst Coverage

    Legend Biotech has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Legend Biotech's stock forecast and price target.
  • Earnings Growth

    Earnings for Legend Biotech are expected to grow in the coming year, from ($1.31) to ($0.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Legend Biotech is -35.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Legend Biotech is -35.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Legend Biotech has a P/B Ratio of 5.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Legend Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    5.25% of the outstanding shares of Legend Biotech have been sold short.
  • Short Interest Ratio / Days to Cover

    Legend Biotech has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in Legend Biotech has recently increased by 23.28%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Legend Biotech does not currently pay a dividend.

  • Dividend Growth

    Legend Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.25% of the outstanding shares of Legend Biotech have been sold short.
  • Short Interest Ratio / Days to Cover

    Legend Biotech has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in Legend Biotech has recently increased by 23.28%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Legend Biotech has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Legend Biotech this week, compared to 7 articles on an average week.
  • Search Interest

    12 people have searched for LEGN on MarketBeat in the last 30 days. This is an increase of 9% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Legend Biotech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Legend Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.02% of the stock of Legend Biotech is held by insiders.

  • Percentage Held by Institutions

    70.89% of the stock of Legend Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Legend Biotech's insider trading history.
Receive LEGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LEGN Stock News Headlines

An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel
See More Headlines

LEGN Stock Analysis - Frequently Asked Questions

Legend Biotech's stock was trading at $32.54 at the beginning of the year. Since then, LEGN shares have decreased by 3.4% and is now trading at $31.44.

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) released its quarterly earnings results on Monday, August, 11th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.22) by $0.12. Legend Biotech's revenue for the quarter was up 36.8% on a year-over-year basis.
Read the conference call transcript
.

Legend Biotech (LEGN) raised $350 million in an IPO on Friday, June 5th 2020. The company issued 18,400,000 shares at $18.00-$20.00 per share. Morgan Stanley, J.P. Morgan Securities and Jefferies served as the underwriters for the IPO.

Shares of LEGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Legend Biotech investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Meta Platforms (META), Arista Networks (ANET), Jabil (JBL) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
8/11/2025
Today
10/07/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LEGN
CIK
1801198
Fax
N/A
Employees
2,609
Year Founded
2014

Price Target and Rating

High Price Target
$86.00
Low Price Target
$54.00
Potential Upside/Downside
+136.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$177.03 million
Net Margins
-40.83%
Pretax Margin
N/A
Return on Equity
-32.00%
Return on Assets
-20.07%

Debt

Debt-to-Equity Ratio
0.30
Current Ratio
4.71
Quick Ratio
4.57

Sales & Book Value

Annual Sales
$627.24 million
Price / Sales
9.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.70 per share
Price / Book
5.52

Miscellaneous

Outstanding Shares
184,570,000
Free Float
184,534,000
Market Cap
$5.80 billion
Optionable
Optionable
Beta
0.23

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:LEGN) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners